{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:17:55Z","timestamp":1793276275555,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008741","name":"European League Against Rheumatism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ard.2025.10.029","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:18:36Z","timestamp":1763698716000},"page":"379-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ultrasound-detected crystal depositions and clinical flares dissolve during successful urate-lowering therapy: 5-year follow-up results from the treat-to-target NOR-Gout study"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7317-8991","authenticated-orcid":false,"given":"Hilde Berner","family":"Hammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Karoliussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Terslev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen A.","family":"Haavardsholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-9552","authenticated-orcid":false,"given":"Till","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ard.2025.10.029_bib0001","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ard.2025.10.029_bib0002","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ard.2025.10.029_bib0003","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13075-016-1062-6","article-title":"Incidence and prevalence of gout in Western Sweden","volume":"18","author":"Dehlin","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ard.2025.10.029_bib0004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1477-7525-10-117","article-title":"Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional survey","volume":"10","author":"Khanna","year":"2012","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"10.1016\/j.ard.2025.10.029_bib0005","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar4281","article-title":"Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR)","volume":"15","author":"Scire","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ard.2025.10.029_bib0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ard.2025.10.029_bib0007","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/annrheumdis-2016-209467","article-title":"Treat-to-target (T2T) recommendations for gout","volume":"76","author":"Kiltz","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ard.2025.10.029_bib0008","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American College of Rheumatology Guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"24","key":"10.1016\/j.ard.2025.10.029_bib0009","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1001\/jama.2014.14484","article-title":"Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England","volume":"312","author":"Kuo","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ard.2025.10.029_bib0010","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","article-title":"Gout: why is this curable disease so seldom cured?","volume":"71","author":"Doherty","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"suppl 1","key":"10.1016\/j.ard.2025.10.029_bib0011","doi-asserted-by":"crossref","first-page":"i51","DOI":"10.1093\/rheumatology\/kex421","article-title":"Education and non-pharmacological approaches for gout","volume":"57","author":"Abhishek","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2025.10.029_bib0012","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fmed.2020.00244","article-title":"Compliance of primary care providers with gout treatment recommendations-lessons to learn: results of a nationwide survey","volume":"7","author":"Sautner","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.ard.2025.10.029_bib0013","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/rheumatology\/kev112","article-title":"International consensus for ultrasound lesions in gout: results of Delphi process and web-reliability exercise","volume":"54","author":"Gutierrez","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.ard.2025.10.029_bib0014","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3899\/jrheum.150366","article-title":"Assessing elementary lesions in gout by ultrasound: results of an OMERACT patient-based agreement and reliability exercise","volume":"42","author":"Terslev","year":"2015","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.ard.2025.10.029_bib0015","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3899\/jrheum.141294","article-title":"Ultrasound as an outcome measure in gout. A validation process by the OMERACT ultrasound working group","volume":"42","author":"Terslev","year":"2015","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.ard.2025.10.029_bib0016","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.semarthrit.2020.11.011","article-title":"Consensus-based semi-quantitative ultrasound scoring system for gout lesions: results of an OMERACT Delphi process and web-reliability exercise","volume":"51","author":"Christiansen","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ard.2025.10.029_bib0017","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/annrheumdis-2020-217392","article-title":"Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study","volume":"79","author":"Hammer","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.10.029_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001628","article-title":"12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target","volume":"7","author":"Uhlig","year":"2021","journal-title":"RMD Open"},{"issue":"SI","key":"10.1016\/j.ard.2025.10.029_bib0019","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab533","article-title":"Two-year reduction of dual-energy CT urate depositions during a treat-to-target strategy in gout in the NOR-Gout longitudinal study","volume":"61","author":"Uhlig","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"10156","key":"10.1016\/j.ard.2025.10.029_bib0020","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ard.2025.10.029_bib0021","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3899\/jrheum.2024-0707","article-title":"Improving gout care in a Canadian Academic Medical Centre through a multidisciplinary, nurse-led protocol","volume":"52","author":"Audet","year":"2025","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.10.029_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004179","article-title":"Optimising gout treatment: insights from a nurse-led cohort study","volume":"10","author":"Rasmussen","year":"2024","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.ard.2025.10.029_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92673-3","article-title":"Healthcare-related impact of gout in hospitalized patients in Spain","volume":"11","author":"Benavent","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ard.2025.10.029_bib0024","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/14397595.2020.1825053","article-title":"Volumetric reduction and dissolution prediction of monosodium urate crystal during urate-lowering therapy - a study using dual-energy computed tomography","volume":"31","author":"Chui","year":"2021","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.ard.2025.10.029_bib0025","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/rheumatology\/keac367","article-title":"Ultrasonography in the prediction of gout flares: a 12-month prospective observational study","volume":"62","author":"Cipolletta","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 3","key":"10.1016\/j.ard.2025.10.029_bib0026","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00393-024-01587-8","article-title":"An observational study of ultrasound semiquantitative scoring for predicting the risk of gout flare","volume":"83","author":"Wang","year":"2024","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.ard.2025.10.029_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152418","article-title":"The value of musculoskeletal ultrasound in predicting gout flares in index joints: a prospective cohort study of people with gout starting urate-lowering therapy","volume":"67","author":"Han","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ard.2025.10.029_bib0028","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X241240837","article-title":"The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout","volume":"16","author":"Yang","year":"2024","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"10","key":"10.1016\/j.ard.2025.10.029_bib0029","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/ard-2024-225761","article-title":"Identifying the association between serum urate levels and gout flares in patients taking urate-lowering therapy: a post hoc cohort analysis of the CARES trial with consideration of dropout","volume":"83","author":"Tedeschi","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.10.029_bib0030","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s42003-024-06534-6","article-title":"Unraveling the pathological biomineralization of monosodium urate crystals in gout patients","volume":"7","author":"Rodriguez-Navarro","year":"2024","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.ard.2025.10.029_bib0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2011.154997","article-title":"Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study","volume":"71","author":"De Miguel","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ard.2025.10.029_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-090415","article-title":"Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohort","volume":"14","author":"Stewart","year":"2024","journal-title":"BMJ Open"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725045170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725045170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:24:59Z","timestamp":1779942299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725045170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0003496725045170"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.10.029","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrasound-detected crystal depositions and clinical flares dissolve during successful urate-lowering therapy: 5-year follow-up results from the treat-to-target NOR-Gout study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}